Anika Therapeutics, Inc. (ANIK) › RevenueAnika Therapeutics, Inc. (ANIK) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $103.38M2017: $113.42M2018: $105.56M2019: $114.61M2020: $130.46M2021: $147.79M2022: $113.83M2023: $120.79M2024: $119.91M2025: $112.82M$112.82M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$112.82M-5.9%2024$119.91M-0.7%2023$120.79M+6.1%2022$113.83M-23.0%2021$147.79M+13.3%2020$130.46M+13.8%2019$114.61M+8.6%2018$105.56M-6.9%2017$113.42M+9.7%2016$103.38M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share